EW
43
4
MSFT
53
3
HBI
55
-4
PX
78
2
MHK
55
6
HBAN
59
2
GWW
74
2
ILMN
46
4
BWA
52
4
COF
63
3
NRG
40
-9
SE
63
2
TGNA
58
2
MCO
80
5
AAL
57
3
WBA
54
6
LB
56
-7
PWR
74
2
FCX
61
3
FE
52
2
EW
43
4
MSFT
53
3
HBI
55
-4
PX
78
2
MHK
55
6
HBAN
59
2
GWW
74
2
ILMN
46
4
BWA
52
4
COF
63
3
NRG
40
-9
SE
63
2
TGNA
58
2
MCO
80
5
AAL
57
3
WBA
54
6
LB
56
-7
PWR
74
2
FCX
61
3
FE
52
2
Financhill
Back

NLS Pharmaceutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33

NLSP
NLS Pharmaceutics

Last Price:
3.48
Seasonality Move:
43.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

NLS Pharmaceutics Price Quote

$3.48
-0.08 (-2.25%)
(Updated: November 26, 2024 at 5:55 PM ET)

NLS Pharmaceutics Key Stats

Sell
33
NLS Pharmaceutics (NLSP) is a Sell
Day range:
$3.37 - $3.65
52-week range:
$3.00 - $29.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
47.1K
Avg. volume:
428.8K
1-year change:
-77.76%
Market cap:
$13.6M
Revenue:
$0
EPS:
$-6.74

How Much Does NLS Pharmaceutics Make?

Data Unavailable

Is NLS Pharmaceutics Growing As A Company?

Data Unavailable

NLS Pharmaceutics Stock Price Performance

  • Did NLS Pharmaceutics Stock Go Up Last Month?
    NLS Pharmaceutics share price went down by -14.83% last month
  • Did NLSP's Share Price Rise Over The Last Year?
    NLSP share price fell by -77.76% over the past 1 year

What Is NLS Pharmaceutics 52-Week High & Low?

NLS Pharmaceutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NLS Pharmaceutics?

  • How Much Debt Does NLS Pharmaceutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does NLS Pharmaceutics Have?
    Cash and short term investments quarterly total is $552.8K
  • What Is NLS Pharmaceutics’s Book Value Per Share?
    Book value per share is -9.40

Is NLS Pharmaceutics Cash Flow Positive?

  • What Is NLSP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$3.9M
  • What Is NLS Pharmaceutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2.8M
  • What Is NLS Pharmaceutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

NLS Pharmaceutics Return On Invested Capital

Data Unavailable

NLS Pharmaceutics Earnings Date & Stock Price

NLS Pharmaceutics Competitors

  • Who Are NLS Pharmaceutics's Competitors?
    Below is a list of companies who compete with NLS Pharmaceutics or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • MoonLake Immunotherapeutics (MLTX)
    • Molecular Partners AG (MOLN)

NLS Pharmaceutics Dividend Yield

NLS Pharmaceutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 240.00
Upside from Last Price: 6641.57%

Major Shareholders

  • How many NLSP shares are owned by institutional investors?
    261K NLSP shares are owned by institutional investors
  • How many NLSP shares are owned by insiders?
    0 NLSP shares are owned by insiders